-
Mashup Score: 1FDA Grants New Indication for Subcutaneous Entyvio - 1 month(s) ago
The FDA expanded indication for the subcutaneous administration of vedolizumab to certain patients with Crohn’s disease.
Source: www.gastroendonews.comCategories: General Medicine News, GastroenterologyTweet
The FDA expanded the indication for the subcutaneous administration of vedolizumab to certain patients with Crohn’s disease. #GITwitter #IBDTwitter #crohns https://t.co/VdFgqFm8jd